|
Real-time Estimate
Cboe BZX
15:06:39 29/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 143.32 USD | -0.13% |
|
-7.49% | -20.95% |
| 10-14 | Axsome Shows Valuation Disconnect Ahead of Q3, RBC Says | MT |
| 10-08 | RBC Trims Price Target on Axsome Therapeutics to $295 From $297, Keeps Outperform Rating | MT |
ETFs positioned on Axsome Therapeutics, Inc.
| Name | YTD change | Weight | AuM | |
|---|---|---|---|---|
 | +16.37% | - | 5,739 M€ | |
| +4.15% | 4.89% | 8 M€ | |
| +11.25% | 2.52% | 222 M€ | |
| +24.01% | 2.47% | 258 M€ | |
| +32.65% | 2.2% | 107 M€ | |
| +25.57% | 2.1% | 1,631 M€ | |
| +16.94% | 2.03% | 520 M€ | |
| +20.94% | 1.89% | 130 M€ | |
| +28.72% | 0.72% | 1,260 M€ | |
| +6.58% | 0.71% | 8 M€ | |
| +11.81% | 0.65% | 937 M€ | |
| +10.71% | 0.63% | 9 M€ | |
| +29.15% | 0.62% | 78 M€ | |
| +29.34% | 0.62% | 1,079 M€ | |
| +29.33% | 0.58% | 9,953 M€ | |
| +27.87% | 0.56% | 81 M€ | |
| +10.21% | 0.54% | 600 M€ | |
| +11.45% | 0.53% | 462 M€ | |
| +19.18% | 0.49% | 13 M€ | |
| +11.58% | 0.49% | 15,028 M€ | |
| +11.28% | 0.43% | 1,568 M€ | |
| +12.98% | 0.42% | 968 M€ | |
| +22.53% | 0.4% | 6,480 M€ | |
| +12.26% | 0.4% | 54 M€ | |
| +15.62% | 0.35% | 4,317 M€ | |
| +7.59% | 0.32% | 12 M€ | |
| +10.80% | 0.3% | 90 M€ | |
| +15.33% | 0.29% | 90 M€ | |
| +17.40% | 0.28% | 1,095 M€ | |
| +1.58% | 0.28% | 186 M€ | |
| +24.11% | 0.27% | 195 M€ | |
| +5.98% | 0.26% | 9 M€ | |
| +14.85% | 0.26% | 1,540 M€ | |
| +15.47% | 0.26% | 82,179 M€ | |
| +9.01% | 0.25% | 18 M€ | |
| +15.59% | 0.23% | 34 M€ | |
| +13.69% | 0.22% | 520 M€ | |
| +19.14% | 0.22% | 205 M€ |
Employees
1,346
Sector
Pharmaceuticals
Calendar
- Stock Market
- Stocks
- AXSM Stock
- ETFs Axsome Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
